Navigation Links
Eisai Pleased to Support Canadian Epilepsy Alliance Comic Book that Teaches Children About Epilepsy
Date:8/21/2014

MISSISSAUGA, ON, Aug. 21, 2014 /CNW/ - Eisai Limited is pleased to support the Canadian Epilepsy Alliance (CEA) in the introduction of the first-of-its-kind comic book available in Canada. The comic book, an innovative educational tool, has been designed specifically to educate children and their parents about epilepsy, the most common neurological disorder in Canada affecting more than 300,000 Canadians. Eisai is guided by a corporate philosophy known as human health care (hhc), in which the patient is central – there was a need within the epilepsy community to help facilitate greater understanding of the disorder for future generations and this certainly aligns with hhc.

"The CEA is always looking for innovative ways to educate Canadians about epilepsy," says Oliver Technow, President and General Manager, Eisai Limited. "Their latest initiative, the MediKidz comic book, takes a unique approach to educating children in a format that resonates, we also know that this will help to inform teachers and parents who may not be familiar with the most common neurological condition in Canada."

Authored by doctors and medical writers, the book's content addresses the mechanics, diagnosis, and treatment of epilepsy and is peer-reviewed by leading medical professionals and endorsed by the Canadian epilepsy community. The MediKidz Explain Epilepsy will be made available through the Canadian Epilepsy Alliance across the country.

About Eisai Limited

Eisai established the Canadian pharmaceutical company Eisai Limited in 2010. As a wholly-owned subsidiary of Eisai Inc., Eisai Limited is based in Mississauga, Ontario, one of the largest biopharmaceutical clusters and medical communities in North America. For more information about Eisai in Canada, please visit www.eisai.ca

About Eisai Inc.

At Eisai Inc., human health care is our goal. We give our first thoughts to patients and their families. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., our passionate commitment to patient care is the driving force. We are a fully integrated pharmaceutical business with discovery, clinical, manufacturing and marketing capabilities. To learn more about Eisai Inc., please visit us at www.eisai.com/US

Eisai Inc. has affiliates that are part of a global product creation organization that includes R&D facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania, as well as a global demand chain organization that includes manufacturing facilities in Maryland and North Carolina. Eisai's global areas of R&D focus include neuroscience; oncology; metabolic disorders; vascular, inflammatory and immunological reaction; and antibody-based programs.


'/>"/>
SOURCE Eisai Limited
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Eisai and Arena Pharmaceuticals Announce Publication of Post-Hoc Analyses of Lorcaserin Phase 3 Clinical Trial Results in Obesity
2. Eisai Oncology to Present New Research on Eribulin and NEPA at 36th Annual San Antonio Breast Cancer Symposium
3. Eisai Joins Groundbreaking Tuberculosis Drug Accelerator Partnership to Discover New Tuberculosis Drugs
4. Eisai Inc. Announces Non-Exclusive Licensing Agreement with Generic Drug Manufacturer to Provide Generic Version of donepezil HCl 23 mg
5. Eisai Launches New Website Providing Employers with Educational Resource for Obesity Management
6. FDA Grants Orphan Drug Status To Eisais Investigational Compound (E7777) For Cutaneous T-Cell Lymphoma
7. For Treating Psoriatic Arthritis, Clinical Data and Thought Leaders Opinions Indicate that AbbVie/Eisais Humira Has the Best Clinical Profile Among Key Marketed Therapies
8. Eisai USA Foundation to Donate $1 Million to the Conquer Cancer Foundation of the American Society of Clinical Oncology
9. Eisai To Sponsor 7th Annual National Walk For Epilepsy To Help Raise Epilepsy Awareness
10. Lynn Kramer, MD, Appointed Chief Clinical Officer of Eisai Product Creation Systems
11. FDA Grants Orphan Drug Status To Eisais Lenvatinib
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2020)... , ... March 30, 2020 , ... ... it has been recognized by Dresner Advisory Services as the #2 vendor in ... capabilities related to data orchestration, data transformation, and data integration for a variety ...
(Date:3/30/2020)... , ... March 30, 2020 , ... ... Aspire Regenerative now offers telemedicine appointments in addition to in-person visits. ... that the safety and well-being of patients, health care professionals, and the community ...
(Date:3/28/2020)... , ... March 28, 2020 , ... TriageLogic, a leader ... to use telehealth system with a virtual call center that hospitals, medical organizations, and ... organizations adapt to the coronavirus pandemic, they are looking for a system that can ...
Breaking Medicine Technology:
(Date:3/22/2020)... ... March 22, 2020 , ... ... may appear to be a frivolous luxury. The world’s focus is on practical ... find some sense of stability and control in chaos. However, it’s during these ...
(Date:3/20/2020)... ... March 20, 2020 , ... CommunityMed Urgent Care , based ... The virtual waiting room lets patients present online, complete registration paperwork (including the latest ... for their turn, and get signaled that their clean exam room is ready. ...
(Date:3/20/2020)... ... March 21, 2020 , ... The ... together for a day of live discussion and learning online. Experts will provide ... telemedicine, whistleblower laws, the role of boards, fraud, waste and abuse, and privacy ...
(Date:3/19/2020)... ... March 19, 2020 , ... For weeks, SignatureCare Emergency Center ... , Earlier this week, it announced that while we are still short of some ... will not wait for our preparedness measures to be complete. , The Houston, TX ...
(Date:3/19/2020)... ... 2020 , ... As confirmed cases of COVID-19 rapidly increase in the United ... global humanitarian organization, Project HOPE’s mandate is always to respond where the need is ... President and CEO of Project HOPE. “We will be supporting America’s health workers as ...
Breaking Medicine News(10 mins):